{"id":1227,"date":"2020-12-17T15:16:39","date_gmt":"2020-12-17T07:16:39","guid":{"rendered":"http:\/\/www.compmedchem.com\/en\/?p=1227"},"modified":"2021-01-10T13:04:04","modified_gmt":"2021-01-10T05:04:04","slug":"senior-ai-rd-scientist","status":"publish","type":"post","link":"http:\/\/www.commedx.com\/en\/senior-ai-rd-scientist\/","title":{"rendered":"Senior AI Drug Research and Development Scientist\/AI Drug Research and Development Scientist"},"content":{"rendered":"\n<p>ComMedX is looking for an Artificial Intelligence (AI) scientists with a strong cheminformatics background. You will be designing and developing cheminformatics algorithms, analyzing massive datasets, and conducting early-stage drug discovery.<\/p>\n\n\n\n<p><strong>Responsibilities<\/strong><\/p>\n\n\n\n<p>\u2022 Develop high-performance machine learning-based algorithms to assist chemists doing retrosynthesis for small molecules.<br>\u2022 Collect compounds building block information, and develop graph-convolutional neural networks or recurrent neural networks to predict the main reaction product and other possible products.<br>\u2022 Training different deep learning algorithms on large numbers of molecules, such as the ZINC database and the ChEMBL database, to generate new molecules by sampling the learned statistical distribution.<br>\u2022 Predict the molecular properties (such as bioactivity, toxicity, solubility, absorption, distribution, metabolism and excretion) using machine learning algorithms.<br>\u2022 Develop new small molecule 3D structure generation and conformation elaboration algorithms.<\/p>\n\n\n\n<p><strong>Qualifications:<\/strong><\/p>\n\n\n\n<p>\u2022 M.Sc\/Ph.D. degree in Computational Chemistry, Organic chemistry, statistics, Cheminformatics, Bioinformatics or a related discipline. The candidates from the top universities or industries worldwide are preferred<br>\u2022 3+ years\u2019 experience in Artificial Intelligence (AI)<br>\u2022 Strong written and communication skills in English<br>\u2022 Strong coding skills in at least one high-level programming language (Python, R, Java, C++, etc)<br>\u2022Ability to work with independence and drive in a startup environment<\/p>\n\n\n\n<p><strong>Preferred:<\/strong><\/p>\n\n\n\n<p>\u2022 Experience in implementing and applying machine learning algorithms in drug discovery projects.<br>\u2022 The experience of 1-3 years in lead optimization at a pharmaceutical company is preferred.<br>\u2022 Understanding the fundamentals of biomolecular interactions.<br>\u2022 Molecular modeling experience is a plus.<br>\u2022 Experience with Chinese or other language (except English) is preferred.<br>\u2022 Experience with cloud computing environments (AWS) .<\/p>\n\n\n\n<p><strong>Compensation &amp; benefits<\/strong><\/p>\n\n\n\n<p>\u2022 Competitive salary, commensurate with experience<br>\u2022 Stock compensation plan \u2013 you\u2019ll be a ComMedX co-owner<br>\u2022 Health, dental, and vision benefits<br>\u2022 Funding for professional development and conference attendance<br>\u2022 Flexible work schedule<br>\u2022 Rental allowance<\/p>\n\n\n\n<p>If you are interested, please send your resume, brief research background introduction and the contact information of the two referees. Email: hr@compmedchem.com\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"<p>ComMedX is looking for an Artificial Intelligence (AI) scientists with a strong cheminformatics background. You will be designing and developing cheminformatics algorithms, analyzing massive datasets, and conducting early-stage drug discovery. Responsibilities \u2022 Develop high-performance machine learning-based algorithms to assist chemists doing retrosynthesis for small molecules.\u2022 Collect compounds building block information, and develop graph-convolutional neural networks &hellip;<\/p>\n<p class=\"read-more\"> <a class=\"\" href=\"http:\/\/www.commedx.com\/en\/senior-ai-rd-scientist\/\"> <span class=\"screen-reader-text\">Senior AI Drug Research and Development Scientist\/AI Drug Research and Development Scientist<\/span> Read More &raquo;<\/a><\/p>\n","protected":false},"author":1,"featured_media":1494,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"default","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","footnotes":""},"categories":[2],"tags":[],"_links":{"self":[{"href":"http:\/\/www.commedx.com\/en\/wp-json\/wp\/v2\/posts\/1227"}],"collection":[{"href":"http:\/\/www.commedx.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.commedx.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.commedx.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/www.commedx.com\/en\/wp-json\/wp\/v2\/comments?post=1227"}],"version-history":[{"count":3,"href":"http:\/\/www.commedx.com\/en\/wp-json\/wp\/v2\/posts\/1227\/revisions"}],"predecessor-version":[{"id":1508,"href":"http:\/\/www.commedx.com\/en\/wp-json\/wp\/v2\/posts\/1227\/revisions\/1508"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/www.commedx.com\/en\/wp-json\/wp\/v2\/media\/1494"}],"wp:attachment":[{"href":"http:\/\/www.commedx.com\/en\/wp-json\/wp\/v2\/media?parent=1227"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.commedx.com\/en\/wp-json\/wp\/v2\/categories?post=1227"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.commedx.com\/en\/wp-json\/wp\/v2\/tags?post=1227"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}